← All stocks

PRECISION BIOSCIENCES INC

DTIL Net buying
CIK 0001357874 #3786 in the set updated 18 Sep 2026
Bought (120 mo)
$2.12M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.59M
$922.34K on a plan · $4.14M straight out of an exercise
Sold at will
$523.94K
15 of 80 sales
Net
−$3.47M
+$1.60M against sales at will

By person

21 insiders · 119 transactions
1.4×

Michael Amoroso holds only 1.4 times base salary in stock. $934.63K of shares against $650.88K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Amoroso last reported holding, valued at $3.84, the price Common Stock was last bought or sold at on the open market here, on 18 Feb 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
JANTZ DEREK
Chief Scientific Officer
$1.62M (17) scheduled
−$1.62M
4,055,174
$15.57M
+5.5%
KANE MATTHEW R.
President and CEO
$1.61M (15) scheduled
−$1.61M
2,024,438
$7.77M
+11.0%
THOMSON DAVID S.
Chief Operating Officer
$1.24M (7) scheduled
−$1.24M
111,513
$428.21K
+2,434%
FMR LLC entity
See Remark 1
$800.00K (1)
+$800.00K
3,738,248
$14.35M
venBio Global Strategic Fund, L.P. entity
Director
$800.00K (1)
+$800.00K
4,265,141
$16.38M
Amoroso Michael
President and CEO
$616.53K (11) scheduled
−$616.53K
243,392
$934.63K
Scimeca Dario
General Counsel and Secretary
$169.10K (13) scheduled
−$169.10K
56,457
$216.79K
SMITH J. JEFFERSON
Chief Research Officer
$122.59K (7) scheduled
−$122.59K
121,926
$468.20K
YAO TONY DUNG LING
Director
$100.03K (1)
+$100.03K
166,903
$640.91K
Buehler Kevin
Director
$63.32K (3)
+$63.32K
49,137
$188.69K
Germano Geno J
Director
$47.57K (3)
+$47.57K
44,883
$172.35K
List Alan
Chief Medical Officer
$45.73K (6)
−$45.73K
4,488
$17.23K
Kelly John Alexander
Chief Financial Officer
$209.27K (7)
$164.22K (4) scheduled
+$45.05K
125,883
$483.39K
Brown Melinda
Director
$43.13K (5)
+$43.13K
44,346
$170.29K
Heery Christopher
Chief Medical Officer
$30.02K (2)
+$30.02K
2,485
$9.54K
Frankel Stanley
Director
$26.11K (2)
+$26.11K
40,478
$155.44K
+80,856%
ANSARI ABID
Chief Financial Officer
144,401
$554.50K
+6,737%
Schinazi Raymond F
Director
93,048
$357.30K
Pire Shari Lisa
Director
35,028
$134.51K
Barton Shane
VP & Corporate Controller
27,502
$105.61K
Wadsworth Samuel C.
Director
4,202
$16.14K

No percentages here. This company's share count has moved by a factor of 3.6 over the window, from 7,671,059 to 27,601,554 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Frankel Stanley
16 Dec 2025
Director
Buy
2,700
$4.70
$12.69K
Germano Geno J
16 Dec 2025
Director
Buy
3,000
$4.72
$14.16K
Brown Melinda
15 Dec 2025
Director
Buy
1,381
$4.97
$6.86K
Frankel Stanley
26 Sep 2025
Director
Buy
2,700
$4.97
$13.42K
Brown Melinda
22 Sep 2025
Director
Buy
1,400
$4.89
$6.85K
Buehler Kevin
25 Jun 2025
Director
Buy
5,076
$4.16
$21.12K
Brown Melinda
25 Jun 2025
Director
Buy
1,682
$4.14
$6.96K
Brown Melinda
26 Mar 2025
Director
Buy
1,839
$4.75
$8.74K
Buehler Kevin
26 Mar 2025
Director
Buy
4,523
$4.67
$21.12K
Germano Geno J
25 Mar 2025
Director
Buy
3,250
$5.30
$17.23K
Germano Geno J
30 Dec 2024
Director
Buy
3,605
$4.49
$16.19K
Kelly John Alexander
27 Dec 2024
Chief Financial Officer
Buy
2,113
$4.75
$10.04K
Buehler Kevin
27 Dec 2024
Director
Buy
4,320
$4.88
$21.08K
Brown Melinda
26 Dec 2024
Director
Buy
3,016
$4.55
$13.72K
Kelly John Alexander
21 Nov 2024
Chief Financial Officer
Buy
3,000
$6.76
$20.28K
Kelly John Alexander
17 Mar 2023
Chief Financial Officer
Buy
20,000
$0.86
$17.20K
Kelly John Alexander
23 Sep 2022
Chief Financial Officer
Buy
8,200
$1.23
$10.09K
Kelly John Alexander
22 Sep 2022
Chief Financial Officer
Buy
37,037
$1.34
$49.63K
Kelly John Alexander
22 Jun 2022
Chief Financial Officer
Buy
33,784
$1.50
$50.68K
Kelly John Alexander
17 Mar 2022
Chief Financial Officer
Buy
16,677
$3.08
$51.37K
Heery Christopher
19 Dec 2019
Chief Medical Officer
Buy
2,235
$12.08
$27.00K
Heery Christopher
19 Dec 2019
Chief Medical Officer
Buy
250
$12.09
$3.02K
YAO TONY DUNG LING
3 Apr 2019
Director
Buy indirect
6,487
$15.42
$100.03K
venBio Global Strategic Fund, L.P.
1 Apr 2019
Director
Buy indirect
50,000
$16.00
$800.00K
FMR LLC
1 Apr 2019
See Remark 1
Buy indirect
50,000
$16.00
$800.00K

What was left out

Form 4 filings counted 235
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 38
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 11,715,028
Sales filed before the plan box existed 8
History held since 29 Mar 2019